Professor Dr. Sorush Niknamian. Ph.D in Cellular and Molecular Biology from the University of Cambridge. He is a CSci (Chartered Scientist), RSciTech (Registered Science Technician), RSci (Registered Scientist) and Science Council, United Kingdom and Indiana Cancer Consortium (ICC) certified. He is the Board member of Weston A. Price Foundation in Washington, United States, Member of American Association for Cancer Research (AACR), Ambassador of European Association for Cancer Research (EACR), Member of Federal Health Professionals in the United States Marine Forces, Army Forces and Military Medicine, Registered Researcher in the U.S. Government's System for Award Management (NAS) and certified member of Royal Society of Biology (MRSB) and the Royal Society of the Great Britain. He has been published 27 books in medical and biological sciences including cancer prevention and treatment. He has published more than 25 research articles in international high impact journals in many fields of medicine. He has been working on cancer treatment, Cause and Prevention alongside Professor Thomas N. Seyfried, Professor Stephanie Seneff, Professor Domonic DíAgostino and Miriam Kalamian. He has hypothesized cancer as an evolutionary metabolic disease (Disorder) and introduced a new protocol in the treatment of cancer. He is a Professional Reviewer at National Institute for Health Research (NIHR), United Kingdom, Editor of the Publishing Research Group, American Society of Clinical Oncology (ASCO), Member of peer review corps at Journal of Clinical Oncology (JCO), JCO Clinical Cancer Informatics, JCO Precision Oncology, Journal of Oncology Practice, Dove Medical Press (Adolescent Health, Medicine and Therapeutics Journal), Dove Medical Press. (Biologics: Targets and Therapy Journal) and Dove Medical Press (Cancer Management and Research) and etc. He is the Guest editor of Nature Medicine Journal and the editorial Board Member of Global Access Publishers (Global Journal of Neurology). He is a nominee of Edison Award 2019.
Dr. Sorush Nik Namian prime research interest is working on the prime cause, prevention and treatment of cancer. Beside this, respiratory medicine, neurological disorders, psychological disorders and their relation to cancer, Evolutionary biology and medicine, Biochemistry, Viral and Fungal diseases, Intravenous Ozone Therapy, multiple Sclerosis, Dementia, Chronic fear and anxiety disorders and their relation to metabolic diseases like cancer, Cancer Biology, biomedicine, introducing and connecting theoretical physics like quantum entanglement to the field of biology.